The active transport of iodide into the thyroid is the first key step for thyroid hormone biosynthesis, which is mediated by the Sodium Iodide Symporter(NIS) at the apical membrane. After molecular cloning of NIS both from rat and man, its function in the physiological and pathological process of thyroid have been fully investigated. Advanced molecular and biochemistrical methods such as cell culture、immuno-histochemistry、RT-PCR、Western-Blot、ELISA and hybridoma were applied to observe the NIS expression in normal and pathological thyroid glands and the influence of hormones、retinoic acid、iodine and cytokines on NIS mRNA expression in thyroid cells, to detect serum NIS autoantibody levels in patients with autoimmune thyroid diseases, to prepare NIS monoclone antibody, and study the significance of NIS in the pathogenesis of thyroid diseases. The study showed that(1)The NIS expression was quite different in thyroid disorders, NIS mRNA could not be detected in thyroid carcinoma tissues except the adjacent normal thyroid tissues, the level of NIS mRNA was highly increased in GD thyroid tissues, while decreased and even undetectable in HT samples. (2) Thyroid regulating factors such as hormones、retinoic acid 、cytokines and iodide could influence NIS expression. The NIS gene expression was elevated by TSH and all-trans retinoic acid, while inhibited by testosterone、dexamethasone、estrogen、TNF-α、IL-6、INF-γand iodine.(3)The level of NIS antibody was significantly higher in GD than healthy subjects and HT patients,while there is no difference in HT patients and healthy subjects.(4)The NIS monoclone antibody was prepared successfully.This study not only revealed the important role of NIS in the pathogenesis of thyroid diseases, but also clarified the regulating effect of hormones、retinoic acid、cytokines and iodide on NIS expression, which boarden the understanding of thyroid homeostasis and pathogensis of AITD. The preparation of NIS monoclone antibody made a solid foundation for further study of its function from protein level.
采用细胞培养、定量RT-PCR、Northern及蛋白印迹等方法,从核酸及蛋白质水平研究正常和病理甲状腺细胞或细胞株表达碘转运体的特征,分析TSH、碘、细胞因子、生长蜃印⑸窬葜始凹鬃聪偬匾煨钥固宥缘庾颂灞泶锏牡骺靥氐悖教值庾颂逶诩鬃聪偕砉δ艿奈趾筒±碜刺姆⑸械淖饔眉耙庖澹鬃聪偌膊〉暮侠碇瘟铺峁┛蒲б谰荨
{{i.achievement_title}}
数据更新时间:2023-05-31
神经退行性疾病发病机制的研究进展
肺部肿瘤手术患者中肺功能正常吸烟者和慢阻肺患者的小气道上皮间质转化
血管内皮细胞线粒体动力学相关功能与心血管疾病关系的研究进展
miR-146a参与不同疾病的研究进展
基于混合泊松分布的新生突变识别算法
HMGB1通过自噬调控甲状腺癌细胞NIS表达及其摄碘率的机制研究
碘缺乏和碘过多对甲状腺生物膜损伤的研究
基于CRISPR/Cas9技术研究钠碘同向转运体在甲状腺癌放射性碘抵抗中的分子作用机制
碘对促甲状腺激素(TSHβ)剪接体表达影响的实验研究